Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5FHZ

Human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid

5FHZ の概要
エントリーDOI10.2210/pdb5fhz/pdb
分子名称Aldehyde dehydrogenase family 1 member A3, NICOTINAMIDE-ADENINE-DINUCLEOTIDE, RETINOIC ACID, ... (4 entities in total)
機能のキーワードhuman, retinaldehyde dehydrogenase, tetramer, product-bound structure, oxidoreductase
由来する生物種Homo sapiens (Human)
細胞内の位置Cytoplasm : P47895
タンパク質・核酸の鎖数8
化学式量合計472001.36
構造登録者
Moretti, A.,Rizzi, M.,Garavaglia, S. (登録日: 2015-12-22, 公開日: 2016-11-02, 最終更新日: 2024-01-10)
主引用文献Moretti, A.,Li, J.,Donini, S.,Sobol, R.W.,Rizzi, M.,Garavaglia, S.
Crystal structure of human aldehyde dehydrogenase 1A3 complexed with NAD(+) and retinoic acid.
Sci Rep, 6:35710-35710, 2016
Cited by
PubMed Abstract: The aldehyde dehydrogenase family 1 member A3 (ALDH1A3) catalyzes the oxidation of retinal to the pleiotropic factor retinoic acid using NAD. The level of ALDHs enzymatic activity has been used as a cancer stem cell marker and seems to correlate with tumour aggressiveness. Elevated ALDH1A3 expression in mesenchymal glioma stem cells highlights the potential of this isozyme as a prognosis marker and drug target. Here we report the first crystal structure of human ALDH1A3 complexed with NAD and the product all-trans retinoic acid (REA). The tetrameric ALDH1A3 folds into a three domain-based architecture highly conserved along the ALDHs family. The structural analysis revealed two different and coupled conformations for NAD and REA that we propose to represent two snapshots along the catalytic cycle. Indeed, the isoprenic moiety of REA points either toward the active site cysteine, or moves away adopting the product release conformation. Although ALDH1A3 shares high sequence identity with other members of the ALDH1A family, our structural analysis revealed few peculiar residues in the 1A3 isozyme active site. Our data provide information into the ALDH1As catalytic process and can be used for the structure-based design of selective inhibitors of potential medical interest.
PubMed: 27759097
DOI: 10.1038/srep35710
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.9 Å)
構造検証レポート
Validation report summary of 5fhz
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon